Graciana Diez-Roux Appointed as New Scientific Director of Fondazione Telethon

Fondazione Telethon has appointed Graciana Diez-Roux as its new scientific director, effective June 15, 2026. According to the organization, Diez-Roux will oversee research investment priorities, manage the integrity of scientific evaluation processes, and lead the strategic integration of intramural and extramural research projects to benefit patients with rare genetic diseases.

Did You Know? Graciana Diez-Roux has been involved with the Fondazione Telethon system since 2003, having served in roles of increasing responsibility at the Telethon Institute of Genetics and Medicine (Tigem) in Pozzuoli.

Strategic focus on young researchers

A primary objective for Diez-Roux in her new role is the support of early-career scientists. She stated that investing in the next generation is fundamental to the foundation’s mission. The organization aims to create new training and employment opportunities, fostering a collaborative research environment that serves the broader scientific community.

Background and scientific credentials

Diez-Roux brings extensive international experience to the position, with an educational background spanning the University of Buenos Aires and New York University. Throughout her career, she has coordinated European projects valued at approximately 70 million euros, focusing on international consortia for rare disease therapies, including lysosomal and retinal conditions. She has also managed strategic industrial alliances with biotech and pharmaceutical companies to facilitate the transition of scientific discoveries into clinical applications.

Expert Insight: Samantha Carter notes that Diez-Roux’s transition from the Tigem research environment to the foundation’s top scientific leadership role suggests a push for greater alignment between laboratory discovery and industrial partnership. By bridging these sectors, the foundation may accelerate the translation of rare disease research into viable therapies.

Future outlook for research initiatives

As the new director, Diez-Roux is expected to strengthen the foundation’s role as a reference point for rare genetic disease research. Analysts expect that her focus on interdisciplinary collaboration could lead to a more integrated research ecosystem. A possible next step involves the implementation of new strategies to maximize the impact of funded activities, ensuring that the foundation continues to prioritize the specific needs of patients within its broader scientific framework.

Frequently Asked Questions

What is Graciana Diez-Roux’s primary goal at Fondazione Telethon?
Her goal is to strengthen the organization’s role in rare genetic disease research by defining investment priorities, ensuring the integrity of scientific evaluation, and integrating intramural and extramural research.

What is the foundation’s stance on early-career scientists?
The foundation aims to prioritize the next generation of scientists by creating new training and employment opportunities and fostering an open, collaborative environment.

What experience does Diez-Roux have with international research?
She has coordinated European projects totaling roughly 70 million euros and has worked extensively with international consortia to develop therapies for rare diseases, including lysosomal and retinal disorders.

How might this leadership change affect the speed of medical breakthroughs for rare disease patients?